Skip to main content
. 2023 May 1;5(2):zcad018. doi: 10.1093/narcan/zcad018

Table 2.

Hits from Z99 scaffold expansion

Compound Inhibition of the RAD52–ssDNA interaction, IC50 (μM) Inhibition of the RPA–ssDNA interaction, IC50 (μM) Inhibition of the RPA–ssDNA–RAD52 complex, IC50 (μM) Toxicity towards BRCA-deficient cells (at 10 μM) Toxicity towards BRCA-proficient cells (at 10 μM)
Z5862216254 7.26 ± 0.61 18.0 ± 1.3 N/A yes (EUFA423F, Capan1, MDA-MB-436) no
Z5862231762 2.84 ± 0.32 28.8 ± 4.0 4.55 ± 0.16 yes/no (Capan1, MDA-MB-436) no
Z5862148469 2.02 ± 0.12 1.12 ± 0.13 0.76 ± 0.05 yes/no (Capan1, MDA-MB-436) no
Z5862209772 7.97 ± 0.84 15.9 ± 1.4 7.00 ± 0.29 yes (EUFA423F, Capan1, MDA-MB-436) no/yes (MCF10a in colony formation assay)
Z5862135983 6.21 ± 0.42 54.0 ± 9.7 54.3 ± 16.2 yes (EUFA423F, Capan1, MDA-MB-436) no/yes (MCF10a in colony formation assay)
Z5862219887 3.98 ± 0.35 8.49 ± 1.43 6.43 ± 1.01 yes (EUFA423F, Capan1, MDA-MB-436) no

N/A – no activity